Relay Therapeutics (RLAY) CEO Sanjiv Patel Sells 48,199 Shares

What Happened

• Sanjiv Patel, President and CEO (and Director) of Relay Therapeutics, reported the sale of 48,199 shares on 2026-08-17. The weighted average sale price was $20.33 per share, for total proceeds of approximately $979,886. This was a sale (often a routine liquidity event), not a purchase.

Key Details

• Transaction date: 2026-08-17; Form 4 filed: 2026-08-18 (timely).
• Price: multiple trades at $19.56–$20.73; weighted average $20.33.
• Shares sold: 48,199; proceeds: ~$979,886.
• Shares owned after transaction: not specified in this filing.
• Footnotes of note:
  • F1: Sale effected under a Rule 10b5-1 trading plan adopted Oct 30, 2025 (prearranged plan).
  • F2: Reported price is a weighted average; reporting person can provide the number of shares sold at each price on request.
  • F3: The filing notes these shares are held in irrevocable trusts for family members with an independent trustee; the reporting person disclaims beneficial ownership of those trust-held securities.

Context

• Trades under a 10b5-1 plan are pre-scheduled and generally viewed as routine execution of a predetermined plan rather than a spontaneous expression of sentiment. The filing does not provide additional company- or insider-level context or indicate any change in corporate role.